NCT04715958View on ClinicalTrials.gov

Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Anatomic Stage III Breast Cancer AJCC v8Locally Advanced Breast Carcinoma
Interventions
PROCEDURE

Contrast-Enhanced Ultrasound

Undergo CEUS

DRUG

Perflutren Lipid Microspheres

Given IV

PROCEDURE

Ultrasound

Undergo unenhanced baseline ultrasound

Trial Locations (3)

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

55905

NOT_YET_RECRUITING

Mayo Clinic, Rochester

75390

RECRUITING

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Kibo Nam

OTHER